Guardian Pharmacy Service... (GRDN)
NYSE: GRDN
· Real-Time Price · USD
23.64
-0.25 (-1.05%)
At close: Aug 15, 2025, 3:59 PM
23.62
-0.06%
After-hours: Aug 15, 2025, 05:05 PM EDT
Guardian Pharmacy Services Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Mar 31, 2021 |
Revenue | 344.33M | 329.31M | 338.57M | 314.39M | 300.04M | 275.41M | 281.07M | 262.74M | 253.44M | 248.95M | 224.08M | 211.05M | 209.89M | 203.59M | 181.31M |
Cost of Revenue | 276.19M | 264.96M | 271.46M | 253.51M | 238.75M | 220.31M | 226.49M | 210.55M | 203.12M | 197.73M | 177.75M | 169.06M | 167.95M | 162.02M | 146.43M |
Gross Profit | 68.15M | 64.35M | 67.1M | 60.88M | 61.29M | 55.1M | 54.58M | 52.19M | 50.32M | 51.22M | 46.33M | 41.99M | 41.94M | 41.57M | 34.88M |
Operating Income | 12.58M | 13.01M | 16.75M | -104.61M | 17M | 7.93M | 15.52M | -6.33M | 25.3M | 6.46M | -1.66M | 21.51M | -1.27M | 15.79M | 2.39M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 12.59M | 13.11M | 16.22M | -105.64M | 15.85M | 7.09M | 14.56M | -7M | 24.44M | 5.71M | -2.16M | 21.02M | -1.74M | 15.39M | 2M |
Net Income | 9.03M | 9.45M | 11.94M | -112.64M | 10.62M | 2.79M | 12.02M | -11.29M | 21.47M | 1.7M | -5.94M | 17.97M | -4.92M | 12.26M | -67K |
Selling & General & Admin | 55.57M | 51.34M | 50.35M | 165.49M | 44.28M | 47.17M | 39.05M | 58.52M | 25.03M | 44.76M | 47.99M | 31.72M | 51.45M | 23.23M | 29.47M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.24M | -8.23M | 2.54M | 3.02M |
Operating Expenses | 55.57M | 51.34M | 50.35M | 165.49M | 44.28M | 47.17M | 39.05M | 58.52M | 25.03M | 44.76M | 47.99M | 20.48M | 43.21M | 25.77M | 32.49M |
Interest Expense | 172K | 170K | 421K | 1.03M | 1.07M | 765K | 739K | 716K | 702K | 702K | 421K | 407K | 398K | 405K | 416K |
Selling & Marketing Expenses | n/a | n/a | 3.5M | n/a | n/a | n/a | n/a | n/a | 37.02M | 36.83M | 33.66M | 31.72M | 38.42M | 23.23M | 29.47M |
Cost & Expenses | 331.75M | 316.3M | 321.81M | 419.01M | 283.03M | 267.48M | 265.54M | 269.07M | 228.14M | 242.49M | 225.74M | 189.54M | 211.16M | 187.79M | 178.92M |
Income Tax Expense | 3.76M | 3.83M | 4.38M | 176K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 62.05M | 62.04M | 61.14M | 61.14M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M |
Shares Outstanding (Diluted) | 63.2M | 62.91M | 61.14M | 61.14M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M |
EPS (Basic) | 0.15 | 0.15 | 0.20 | -2 | 0.17 | -0.3 | 0.20 | -0.19 | 0.35 | 0.03 | -0.1 | 0.30 | -0.08 | 0.20 | -0.00 |
EPS (Diluted) | 0.14 | 0.15 | 0.20 | -2 | 0.17 | -0.3 | 0.20 | -0.19 | 0.35 | 0.03 | -0.1 | 0.30 | -0.08 | 0.20 | -0.00 |
EBITDA | 18.25M | 18.54M | 21.8M | -99.62M | 16.91M | 12.61M | 20.01M | -1.64M | 29.57M | 10.87M | 2.28M | 25.5M | 2.77M | 18.5M | 6.68M |
EBIT | 12.76M | 13.28M | 16.64M | -104.61M | 16.91M | 7.86M | 15.3M | -6.28M | 25.14M | 6.42M | -1.74M | 21.43M | -1.35M | 15.79M | 2.42M |
Depreciation & Amortization | 5.49M | 5.27M | 5.15M | 4.99M | n/a | 4.75M | 4.71M | 4.64M | 4.42M | 4.46M | 4.02M | 4.07M | 4.12M | 2.71M | 4.27M |